Akyso Therapeutics
UEI: WMJ6UFULU731
• CAGE: 83GL0
Overview
Awardee Type
Parent
Company Description
Akyso - Sustained Release Drug Delivery
Name
Akyso Therapeutics
Website
Headquarters
Saint Petersburg, FL
United States
United States
Most Recent Award
Aug. 1, 2025
Calculating
Federal grant recipient
AKYSO THERAPEUTICS, LLC
(UEI WMJ6UFULU731, CAGE 83GL0)
is headquartered in Saint Petersburg FL.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The partnership
was founded in April 2014 and
federally registered in
April 2018.
Federal Award Analysis
Akyso Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
AKYSO THERAPEUTICS, LLC
UEI
WMJ6UFULU731
CAGE Code
83GL0
SBA Certifications
None
Self Certifications
For Profit Organization, Limited Liability Company
Entity Structure
Partnership or Limited Liability Partnership
Purpose of Registration
Federal Contracts and Assistance
Date Founded
April 11, 2014
Initial Registration
April 24, 2018
Last Registration
Feb. 5, 2026
Registration Activation
Feb. 5, 2026
Registration Expiration
Jan. 28, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
FL
Country of Incorporation
USA
Employees
Not Available
Accepts Credit Cards
No
People
Vendor contacts at Akyso Therapeutics
Grant Awards
Akyso Therapeutics direct grants
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Akyso Therapeutics